Bedard-Gilligan, Michele http://orcid.org/0000-0002-3109-3006
Lehinger, Elizabeth
Cornell-Maier, Sarah
Holloway, Ash
Zoellner, Lori
Funding for this research was provided by:
National Institute on Drug Abuse (R34DA040034)
Article History
Accepted: 20 April 2022
First Online: 15 June 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study referenced in this article.
: Author Bedard-Gilligan’s spouse owns stock in Forefront, a medicinal and recreational cannabis company. He currently works and owns stock at Treez, a software company that supports the legal cannabis industry. Authors Lehinger, Holloway, Cornell-Maier, and Zoellner have no conflicts of interest to disclose.